COMPOSITION:
Each film-coated sustained release tablet contains:
Acebrophylline ……….200 mg
Acebrophylline is a xanthine derivative and is primarily used as a bronchodilator in the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD) in adults.
MECHANISM OF ACTION:
Mucus Modification: Acebrophylline alters the mucus gel secretion phase by reducing its viscosity and increasing the serous gel phase. This makes mucus less sticky and easier to clear.
Ciliary Motility: It enhances the movement of the cilia (tiny hair-like structures in the respiratory tract), which helps in clearing mucus from the airways more efficiently.
Mucociliary Clearance: By improving ciliary motility and modifying mucus properties, Acebrophylline increases mucociliary clearance, thereby helping to keep the airways clear of mucus.
USES:
Bronchial Asthma: Helps in reducing symptoms and improving breathing.
COPD: Aids in managing symptoms and enhancing the quality of life for individuals with chronic obstructive pulmonary disease.
ADMINISTRATION:
Typically administered orally in tablet form. Dosage and frequency should be as prescribed by a healthcare provider, based on individual patient needs.
DISCLAIMER: All content published online is for informational purposes only. It is not intended to be a substitute for professional medical advice. Always seek the guidance of your doctor with any questions you may have regarding your health, medical condition, or any medicines.